Carbapenem-resistant Acinetobacter baumannii (CRAB) has been implicated in hospital outbreaks worldwide. Here, we present a whole-genome-based investigation of an extensively drug-resistant CRAB outbreak rapidly spreading and causing high incidences of mortality at numerous wards of a large tertiary hospital in Lebanon. This is the first study of its kind in the region. Two circulating clones were identified using a combination of molecular typing approaches, short- and long-read sequencing and Bayesian transmission network analysis. One clone carried blaOXA-23 on Tn2006 (ST-1305, ST-195, and ST-218), and another carried blaOXA-72 on a pMAL-1 plasmid (ST-502 and ST-2059, a new ST). A pMAL-2 plasmid was circulating between the two clones. The approaches implemented in this study and the obtained findings facilitate the tracking of outbreak scenarios in Lebanon and the region at large.
KEYWORDS: A. baumannii, CRAB, Tn2006, pMAL-1, hospital outbreak
ABSTRACT
Carbapenem-resistant Acinetobacter baumannii (CRAB) is an important opportunistic pathogen linked to a variety of nosocomial infections and hospital outbreaks worldwide. This study aimed at investigating and characterizing a CRAB outbreak at a large tertiary hospital in Lebanon. A total of 41 isolates were collected and analyzed using pulsed-field gel electrophoresis (PFGE). Whole-genome sequencing (WGS) was performed on all the isolates, and long-read PacBio sequencing was used to generate reference genomes. The multilocus sequence types (MLST), repertoire of resistance genes, and virulence factors were determined from the sequencing data. The plasmid content was analyzed both in silico and using the A. baumannii PCR-based replicon typing (AB-PBRT) method. Genome analysis initially revealed two clones, one carrying blaOXA-23 on Tn2006 (ST-1305, ST-195, and ST-218) and another carrying blaOXA-72 on pMAL-1 (ST-502 and ST-2059, a new ST), with the latter having two subclones, as revealed using the Bayesian transmission network. All isolates were extensively drug resistant (XDR). WGS analysis revealed the transmission pathways and demonstrated the diversity of CRAB isolates and mobile genetic elements in this health care setting. Outbreak detection using WGS and immediate implementation of infection control measures contribute to restraining the spread and decreasing mortality.
IMPORTANCE Carbapenem-resistant Acinetobacter baumannii (CRAB) has been implicated in hospital outbreaks worldwide. Here, we present a whole-genome-based investigation of an extensively drug-resistant CRAB outbreak rapidly spreading and causing high incidences of mortality at numerous wards of a large tertiary hospital in Lebanon. This is the first study of its kind in the region. Two circulating clones were identified using a combination of molecular typing approaches, short- and long-read sequencing and Bayesian transmission network analysis. One clone carried blaOXA-23 on Tn2006 (ST-1305, ST-195, and ST-218), and another carried blaOXA-72 on a pMAL-1 plasmid (ST-502 and ST-2059, a new ST). A pMAL-2 plasmid was circulating between the two clones. The approaches implemented in this study and the obtained findings facilitate the tracking of outbreak scenarios in Lebanon and the region at large.
INTRODUCTION
Acinetobacter baumannii is associated with a broad range of severe wound, skin and soft-tissue, urinary tract, and bloodstream infections, secondary meningitis, and ventilator-associated pneumonia (1). These often result in extended periods of hospitalization and admission to intensive care units (ICUs) (2). A. baumannii survives inside human hosts, on dry surfaces, and on the hands of health care personnel for prolonged periods, and it is often associated with worldwide hospital outbreaks (3, 4).
A. baumannii infections are difficult to treat, having both intrinsic and acquired drug resistance determinants carried on plasmids, transposons, and integrons (5–7). Carbapenem resistance is mostly mediated by oxacillinases (OXAs) and less frequently by metallo-β-lactamases (MBLs) (8). The marked overproduction of class D β-lactamases (CHDLs) is the main mechanism conferring carbapenem resistance in A. baumannii and is caused by intrinsic genes encoding OXA-51-like enzymes and other families of OXA-type CHDLs, including OXA-23-like, OXA-40-like, OXA-58-like, and OXA-143 enzymes (9). The frequency of CHDLs and MBLs in A. baumannii varies in different geographic regions (10).
OXA-51 is the largest group of intrinsic OXA-type β-lactamases identified. It was originally detected in 1996 in A. baumannii recovered from Argentina, and later it became an important marker used for the identification of the organism at the species level (11, 12). ISAba1 has been identified in association with different OXA-β-lactamases, including the blaOXA-51-like genes. ISAba1 is located 7 bp upstream in the opposite direction of blaOXA-51-like and provides a promoter that can increase blaOXA-51-like gene expression levels by 50-fold (12, 13).
OXA-23 was first identified in A. baumannii strains isolated in the United Kingdom in 1993. Since then, it has been detected worldwide and was linked to the global dissemination of carbapenem-resistant A. baumannii (CRAB) (14–16). Al Atrouni et al. showed that 76.5% of the A. baumannii isolates collected from different hospitals in Lebanon were carbapenem resistant, with the majority (90%) harboring the OXA-23 carbapenemase (17). More recent studies revealed that carbapenem susceptibility among Acinetobacter isolates was 12% (18), and most of the recovered isolates (83%) were susceptible to colistin (19). Moreover, OXA-24 has several variants, including OXA-72. Isolates carrying blaOXA-72 were associated with a number of hospital outbreaks in Spain, Ecuador, and the United States (13, 16).
In this study, we describe the molecular epidemiology of a CRAB-associated outbreak linked to Tn2006- and pMAL-1-mediated clones. The results obtained through whole-genome sequencing (WGS) and single-nucleotide polymorphism (SNP) analysis of 41 isolates collected in 2016 from a hospital in Lebanon were compared to the subtyping patterns obtained by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). WGS data were additionally used to compare the two identified outbreak clones, build transmission networks, explore the genetic relatedness of the isolates causing the outbreak, study their resistomes and virulomes, and determine their circulating mobile genetic elements.
RESULTS
Clinical characteristics.
A total of 41 A. baumannii isolates were collected between April and December 2016 from hospitalized patients. Patients’ records were available for 37 of the isolates, designated ACM-1 to -37. These were recovered from 23 different patients with a mean age of 53 ± 27 years, ranging between newborn and 92 years old. Of these, 65% (n = 15) were females and 35% (n = 8) were males, and more than half of the patients (61%; n = 14) died due to different causes, including underlying diseases (Fig. 1; see also Table S1 in the supplemental material).
Isolates ACM-10 and -14 were found to be A. calcoaceticus and were not part of the outbreak. ACM-14 was used as an outgroup in the phylogenetic analysis. Isolate ACM-26 was a mixed culture (different strains of A. baumannii) recovered from a 3-year-old male patient.
Antibiotic susceptibility testing and resistance genes.
Antibiotic susceptibility testing was performed on the 41 A. baumannii isolates, and 92.8% (n = 38) were found to be nonsusceptible to both gentamicin and amikacin. ACM-13 showed intermediate resistance to amikacin and was susceptible to gentamicin. Most of the isolates were quinolone resistant; 95% (n = 39) were resistant to ciprofloxacin, 92.8% (n = 38) were resistant to levofloxacin, and one isolate (ACM-3) showed intermediate resistance to levofloxacin. Additionally, 95% (n = 39) were resistant to ceftazidime, imipenem, meropenem, and piperacillin-tazobactam, and 82.9% (n = 34) were resistant to cefepime. All isolates were susceptible to colistin, as determined by the obtained MIC values. Based on the findings described above, 95% of the isolates were classified as being extensively drug resistant (XDR) (20) (Fig. 2).
The antibiotic susceptibility testing results were confirmed through in silico detection of resistant determinants. Four different aminoglycoside-inactivating enzymes and their variants were detected. Aminoglycoside acetyltransferase (AAC) aac(3′)-Ia and ant(3″)-Ia, belonging to the aminoglycoside nucleotidyltransferase (ANT) family, were found in 56% (n = 23) and 53.6% (n = 22) of the isolates, respectively. Five variants of the aminoglycoside phosphotransferase (APH) enzyme were also identified. The most common was aph(3′)-VIa, being detected in 73% (n = 30) of the isolates. strA and strB variants of the aph enzyme were detected in 46.3% (n = 19), aph(3′)-Ia in 34% (n = 14), aph(6′)-Id in 2.4% (n = 1), and armA in 46.3% (n = 19) of the isolates.
Acinetobacter-derived cephalosporinase genes blaADC-73 and blaADC-74 were identified in 62.5% (n = 25) and 37.5% (n = 15) of the isolates, respectively. ISAba1 was detected upstream of blaADC-73 and blaADC-74 in the opposite direction. All of the isolates carried blaOXA-66, while only ACM-14 was positive for blaOXA-359. Class A β-lactamase (blaTEM-1D), in addition to macrolide resistance determinants mph(E) and msr(E), were also found in 31.7% (n = 13) and 44% (n = 18) of the isolates, respectively.
PFGE.
As we suspected an outbreak scenario, we first typed the isolates using PFGE. Isolates showing a difference of more than three bands were classified as belonging to different pulsotypes (21). Accordingly, 21 different pulsotypes were identified and were aligned with the STs but not with the source of isolation. The isolates, based on the PFGE output, appeared to be circulating in the different wards of the hospital. The first clade included ST-195, ST-218, ST-425, ST1305, and ST-502, while the second included ST-502 and ST-2059, a new ST, in addition to ST-218 and ST-425 (Fig. 1).
MLST.
In silico MLST analysis, based on seven housekeeping genes (cpn60, gdhB, gltA, gpi, gyrB, recA, and rpoD) using the Oxford scheme, revealed the presence of eight different STs compared to only five STs identified using the Pasteur MLST scheme. Given that the Oxford MLST scheme was more capable at differentiating between closely related isolates, we adopted it for all further analysis. ST-502, CC92 (2-3-1-100-12-2-3) (ST-636, CC2 Pasteur scheme), which was the most common (44%; n = 18), and ST-502-like (ST-2059, a new ST), CC92 (ST-636, CC2 Pasteur scheme), were detected among the studied isolates. The difference between ST-502-like (ST-2059) and ST-502 is three point mutations in the rpoD gene, a G→T substitution at 117th base pair position, a G→T substitution at the 366th position, and a T→C substitution at the 504th position. ST-218, CC92 (2-3-1-102-3-2-3) (ST-2, CC2 Pasteur scheme), and ST-195, CC92 (2-3-1-96-3-2-3) (ST-2-like, CC2 Pasteur scheme), represented 27% (n = 11) and 17% (n = 7) of the isolates, respectively. Two singletons, ST-1305, CC208 (2-3-1-96-12-2-3; ACM-7) (ST-2-like, CC2 Pasteur scheme), and ST-425, CC92 (2-3-1-100-3-2-3; ACM-39) (ST-2-like, CC2 Pasteur scheme), were also among the detected ST types.
Mobile genetic elements.
The A. baumannii PCR-based replicon typing (AB-PBRT) method was used to characterize the circulating plasmids. AB-PBRT categorizes A. baumannii plasmids into homology groups (GRs) based on the nucleotide homology of their respective replicase genes. AB-PBRT results showed that 21.9% (n = 9) of the isolates carried homology group GR2, 2.4% (n = 1) carried GR6, and 68.3% (n = 28) carried both GR1 and GR6, related to a wide range of plasmids (22).
Tn2006-linked clone.
Nineteen CRAB (46.3%) isolated from 14 patients carried the blaOXA-23 carbapenemase gene in addition to intrinsically carrying blaOXA-66. These constituted the Tn2006-linked circulating clone in the outbreak. blaOXA-23 is usually associated with plasmids or integrated through transposons into the A. baumannii chromosome (10). These transposons are highly diverse and were designated Tn2006, Tn2007, Tn2008, and Tn2009 (23). blaOXA-23 was carried by a chromosomally integrated Tn2006. The mobilization of Tn2006, being detected in ST-195, ST-218, and ST-1305, was facilitated by the ISAba1 bracketing of blaOXA-23. The remaining constituents of Tn2006 were yeeA (encoding the putative DNA methylase), DEAD (encoding the putative Asp-Glu-Ala-Asp helicase), and ATPase (encoding the putative AAA ATPase) genes.
The integration site of Tn2006 was the same among all the isolates of the Tn2006-linked clone. Tn2006 was integrated inside a dienelactone hydrolase family protein, dividing it into two fragments, one 670 bp upstream of Tn2006 and a smaller 145-bp fragment downstream of Tn2006.
Tn2006 was associated with the AbaR25 resistance island, as has been previously described for Tn2006 (23, 24). AbaR25 had the same genetic environment as AbaR25-I type (24).
The Tn2006-linked clone (ACM-2-6, ACM-8, ACM-9, ACM-34, ACM-36, and ACM-37) also harbored a circulating cryptic plasmid showing 100% BLAST sequence similarity to pA85-2 (GenBank accession number CP021786) and to pAB0057 (GenBank accession number CP001183) (8). The plasmid was also 99.99% similar to pAb-G7-1 (GenBank accession number KJ586856) (25), with only one base pair substitution difference (A→C). pA85-2 carried no resistance determinants but harbored a BrnT/BrnA toxin-antitoxin system, TonB-dependent receptor, and several hypothetical proteins, including septicolysin.
Interestingly, ACM-7 and ACM-28 carried both a chromosomal Tn2006 mobilizing blaOXA-23 and a pMAL-1 plasmid carrying blaOXA-72, with no evidence of blaOXA-72 exchange between the plasmid and the chromosome (Table S2).
pMAL-1-linked clone.
Nineteen ST-502/2059 CRAB (48.7%) isolates were recovered from 15 patients and harbored the intrinsically carried blaOXA-66 in addition to blaOXA-72. Genome analysis of ACM-17, a representative of OXA-72-producing isolates, revealed that blaOXA-72 was carried on a small 9,810-bp plasmid that was identical to a previously identified GR2 plasmid in A. baumannii isolated from Serbia in 2016 and designated pMAL-1 (GenBank accession no. KX230793.1). Subsequently, BLAST analysis and genome alignments showed that the remaining ST-502 isolates also carried the same pMAL-1 plasmid. This plasmid was conjugative and had a genetic backbone identical to that of pMAL-1, being in the same order and orientation as repAci1-repAci2 (replicase genes), two XerC/XerD sites (tyrosine recombinase sites) bracketing blaOXA-72, as well as ISAba31, tonB, sep (septicolysin-encoding gene), and a few hypothetical proteins. Other plasmids were also closely related to the one detected in this study, including pA105-2 (GenBank accession number KR535993.1), isolated from A. baumannii in 2015, p2ABST25 (GenBank accession number AEPA01000396.1; negative for ISAba31), and pAB0057 (GenBank accession number NC_011585.1; differing in the region flanking XerC/XerD; replaced by blaOXA-72 and ISAba31 in pMAL-1) (Fig. 3).
ACM-11, ACM-17, ACM-25, and ACM-35, which were part of the pMAL-1 clone, harbored other plasmids, such as pTG22653 (GenBank accession number CP039519.1) and ABAY04001 (GenBank accession number MK386680.1) (Table S2).
pMAL-2 circulating plasmid.
In ACM-4, ACM-7, and ACM-29, representing the Tn2006-linked clone, and in ACM-12, ACM-15, ACM-25, ACM-31, ACM-35, and ACM-41, representing the pMAL-1-linked clone, we detected a common 70,499-bp plasmid. The plasmid was 100% identical to pAB-MAL-2 (GenBank accession number KX230794.1) (26) but had additional hypothetical proteins and a toxin-antitoxin (TA) higAB system. pAB-MAL-2 carried the tellurite resistance gene in addition to a Zeta toxin family protein, an ornithine cyclodeaminase, and many hypothetical proteins with unknown functions while being negative for antibiotic resistance determinants (Table S2 and Fig. S1 to S3).
In order to better characterize the higAB system found on pAB-MAL-2, we compared it with a recently described plasmid, pAB120, having the higBA2Ab TA module (27). Alignment of the TA components revealed 60.3% and 58.8% similarity to higB2 and higA of pAB120, respectively. The higAB system was preceded by ISAba125 (Fig. S1). BLAST analysis showed 100% identity to higB2 of A. baumannii ACICU plasmid pACICU2 (GenBank accession number CP031382) and to the type II toxin-antitoxin system RelE/ParE in many other A. baumannii plasmids. higA was 100% identical to antitoxin higA1, linked to A. baumannii ACICU plasmid pACICU2 and to transcriptional regulators in other A. baumannii plasmids.
Whole-genome SNP phylogenetic analysis.
In total, 71,864 SNP sites were identified. Isolates were separated into two major clusters, of which two representative genomes were chosen to be additionally sequenced using PacBio long-read sequencing technology, ACM-2 (representing the isolates carrying blaOXA-23 and forming the Tn2006-mediated clone) and ACM-17 (representing the isolates carrying blaOXA-72 and forming the pMAL-1-mediated clones). The results obtained confirmed the presence of two circulating clones. A total of 1,207 SNP sites were detected in the Tn2006-linked clone, while only 57 SNPs were detected in the pMAL-1-linked clone (Fig. 2).
Outbreak analysis.
To reconstruct the suspected outbreak based on statistical analyses and core genome alignments, and taking into consideration collection dates, we used the R package Outbreaker (28). Outbreaker allows for a Bayesian reconstruction of disease outbreaks by combining both epidemiologic and genomic data. As a result, a bell-shaped distribution of the mutations per site and generation was observed in the case of the Tn2006-linked clone, along with a tight clustering of the isolates in an interconnected nodular network (Fig. S4). Clearly localized SNP-generating hot spots were favored to produce genomic diversity, as both recombination- and non-recombination-induced single-nucleotide variants almost always occurred in a few defined regions (SNP density ranging from 0.0003 to 0.0012). This included genes encoding diacylglycerol kinase, 3′,5′-cyclic-nucleotide phosphodiesterase, BapA prefix-like domain-containing protein, translation error-prone DNA polymerase V autoproteolytic subunit, and epoxyqueuosine reductase QueH. An exponential decrease of the infectivity of the cases based on the probability of infecting another patient up to 20 days after infection was observed (Fig. S5).
On the other hand, in the pMAL-1-linked clone, the pairwise genetic distances had a clear bimodal distribution showing two bell-shaped curves (Fig. 4A). Based on this distribution, we speculated that the pMAL-1-linked clone encompassed two subclones. The mean mutation rate was 10, ranging from 0 to 18 for subclone I, while for subclone II we found 35 mutations, ranging between 28 and 45 (Fig. 4B). A high density of SNPs (ranging between 2 × 10−4 and 10 × 10−4) was observed within specific loci in the core genomes. These were genes encoding BapA prefix-like domain-containing protein, DUF2750 domain-containing protein, stress-induced protein, and putative pilus assembly protein FilE.
DISCUSSION
In this study, a CRAB hospital outbreak caused by two distinct clones was tracked using PFGE, MLST, and WGS analysis over 9 months. Our analysis revealed a pMAL-1-linked clone, including ST-502 and ST-2059 isolates carrying blaOXA-72, along with two distinct subclones. A second Tn2006-linked clone was also identified, including ST-1305, ST-195, and ST-218 and carrying blaOXA-23. Both clones were circulating in different hospital wards and causing similar rates of mortality. WGS analysis was used to understand and elucidate the transmission pathways and to demonstrate the diversity of CRAB isolates and the associated mobile genetic elements.
The mobilization and spread of the chromosomal Tn2006 transposon to three different STs (ST-195, ST-218, and ST-1305) was facilitated by the presence of two copies of ISAba1 upstream and downstream of blaOXA-23. Interestingly, out of the many transposons carrying the blaOXA-23 gene, only Tn2006 has been shown to be highly mobile (29). blaOXA-23 was originally identified in Acinetobacter radioresistens, with blaOXA-23-mediated resistance to carbapenem being detected only in the presence of a strong promoter, such as ISAba1 (29). ISAba1, which belongs to the IS4 family of insertion sequence elements, provides a promoter motif mediating the increased expression of blaOXA-23 and is involved in facilitating its own mobilization not only to A. baumannii but also to Proteus mirabilis (10). Upon its first description in 1995 in A. baumannii, blaOXA-23 carried on plasmids or transposons became widespread and was detected in isolates recovered from the United Kingdom, France, Romania, Brazil, South Korea, United Arab Emirates, Egypt, and Iraq (10, 30, 31). blaOXA-23 was detected previously in GC2 CRAB isolates in Lebanon and was recognized as being the most common carbapenemase in the country (17, 30). The Tn2006-linked clone also carried a cryptic pA85-2 plasmid that appears to be commonly found in the GC1 lineage (32). The advantage conferred by this plasmid is still unknown.
The pMAL-1-linked clone included ST-502 and ST-2059 isolates and harbored the blaOXA-72 gene. This is the first report of ST-502 and ST-2059 A. baumannii in Lebanon. Carbapenem-resistant ST-502 isolates have been reported previously in Brazil (33), Bulgaria (34), and South Africa (35). blaOXA-72 was first identified in 2004 in A. baumannii isolated from Taiwan, and since then it was detected in a few other countries, including Brazil, France, and the United States (36). The pMAL-1 plasmid was very similar to p2ABST25, with the latter being negative for ISAba31 (26). The presence of ISAba31 upstream of blaOXA-72 has been reported previously in pMAL-1 (26), yet its effects on blaOXA-72 expression require further investigations. No previous reports showed the presence of p2ABST25-positive isolates in Lebanon or any of the neighboring countries, and as such pMAL-1 could have been introduced rather than evolved from another circulating plasmid.
We also revealed that the Tn2006-linked clone harbored a pA85-2 plasmid carrying persistence- and virulence-related genes, such as a BrnT/BrnA toxin-antitoxin system, a TonB-dependent receptor, and a septicolysin. The BrnT toxin-antitoxin system is required for RNA cleavage and control of bacteriostasis in Brucella abortus (37). TonB-dependent transporters are outer membrane proteins that bind and transport siderophores in addition to vitamin B12, nickel complexes, and carbohydrates (38). Septicolysin, on the other hand, is a pore-forming toxin with cytolytic activity that mediates invasion (39).
The pAB-MAL-2 plasmid was found circulating in both the Tn2006- and the pMAL-1-linked outbreak clones. pAB-MAL-2 detected in this study was slightly different from that in previous reports (26). The plasmid was additionally positive for a TA system showing 60% similarity to a recently described higBA2Ab TA module on pAB120 (27). The higAB system found on the pAB-MAL-2 plasmid in our isolates was preceded by ISAba125. ISAba125 was previously associated with the dissemination of blaNDM-1 (40). The presence of ISAba125, a strong promoter, upstream of the TA system (41) is an important finding. TA systems are genetic loci involved in plasmid maintenance and in regulating bacterial stress responses linked to pathogen virulence and formation of drug-resistant persister cells and biofilms (42). The higBA2 gene detected in this study is a reverse TA, where the toxin gene is the first in the operon. HigB2 functions as an RNase capable of conferring maintenance of unstable plasmid in Acinetobacter, and it is neutralized with HigA2 antitoxin (27).
A total of 1,207 SNP sites were detected within the Tn2006-linked clone harboring blaOXA-23, compared to only 57 SNP sites identified within the pMAL-1-linked clone harboring blaOXA-72. Bayesian analysis revealed the transmission events with a high degree of certainty. During the outbreak, the isolates underwent genomic remodeling at clearly defined loci. Recombination events, as well as increased variance in the nucleotide sequences within a few genes, served as the primary drivers of diversity. In particular, and in both clones, a high density of SNPs was observed in BapA, a biofilm-associated protein mediating biofilm formation and adhesion to host cells (43). In the Tn2006-linked clone, one of the genes that accumulated a large number of SNPs encoded a diacylglycerol kinase, a small integral membrane protein (44). Diacylglycerol kinase was previously shown to be upregulated in colistin-resistant A. baumannii and was hypothesized to increase the integrity of the cell membrane, favoring drug resistance (45).
In conclusion, by following the pattern of transmission and based on the molecular epidemiology and genomics data, we confirm the polyclonal nature of the outbreak. Using PFGE, MLST, and PCR typing methods in combination with WGS data and SNP-based Bayesian transmission network analysis, we were able to characterize at high-scale resolution a hospital CRAB outbreak caused by a Tn2006-linked clone carrying blaOXA-23 and a pMAL-1-linked clone carrying blaOXA-72. An outbreak driven by chromosomally encoded resistance determinants had a more consistent evolution and was easier to retrace using core genome sequence data from short genome reads. Alternatively, a plasmid-driven outbreak followed less of a straight evolutionary path during the sampling. Both clones additionally harbored circulating plasmids, ensuring the survival of the fittest and contributing to virulence.
MATERIALS AND METHODS
Ethical approval.
Ethical approval was not required, as the isolates were collected as part of routine clinical care and patient data collection followed patient discharge from the hospital and/or death. No additional isolates were collected beyond those obtained from routine clinical care, and no diagnostic or treatment decisions were affected by the outcomes of this study.
Bacterial isolates.
A total of 41 A. baumannii isolates were collected between April and December 2016 from hospitalized patients at a 544-bed hospital in Lebanon and were designated ACM-1 to -37 based on the date of their isolation and ACM-38 to -41 for the isolates with no trackable records. The initial identification of Acinetobacter species was carried out using automated microbial identification systems (Vitek and BD Phoenix).
Antimicrobial susceptibility testing.
Antimicrobial susceptibility testing was performed using the disk diffusion method on Mueller-Hinton agar to determine resistance patterns against nine different antibiotics: gentamicin, amikacin, piperacillin-tazobactam, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, and levofloxacin. The results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines (M100-S29) (46). Isolates were considered extensively drug resistant (XDR) if they were nonsusceptible to at least one agent in all but two or fewer antimicrobial classes (20).
MICs were determined using the Etest (bioMérieux, France) method for gentamicin, cefepime, ciprofloxacin, trimethoprim-sulfamethoxazole, amikacin, piperacillin-tazobactam, and colistin and the broth microdilution method for colistin, meropenem, and imipenem (Sigma-Aldrich, USA). For the Etest, bacterial suspensions with turbidity equivalent to 0.5 McFarland standard were prepared and spread onto Mueller-Hinton agar (MHA) (Bio-Rad Laboratories, Inc., USA), followed by the addition of Etest strips. The plates then were incubated at 37°C for 24 h. For the broth microdilution method, cation-adjusted Mueller-Hinton broth (Sigma-Aldrich, USA) was used according to CLSI recommendations. Serial dilutions of each of the three antibiotics (32 to 0.062 μg/ml) were prepared. A. baumannii isolates were suspended to 0.5 McFarland turbidity and added to 96-well microdilution plates. Microplates were incubated at 35°C for 20 to 24 h. The lowest antimicrobial drug concentration at which there was no growth was considered the MIC.
PFGE.
Genomic DNA plugs of A. baumannii were prepared according to the protocol developed by Seifert et al. (47). Briefly, plugs were digested using ApaI (Thermo Fisher Scientific, MA, USA) for 2 h at 37°C. DNA fragments were then separated on 1% Seakem Gold gel using a CHEF DR-III system (Bio-Rad Laboratories, Inc., CA, USA) for 16 h with initial and final switch time of 7 s and 20 s, respectively. To compare the patterns on different gels, Salmonella enterica subsp. enterica serovar Braenderup (ATCC BAA664TM) was used as the reference for band size using XbaI restriction digestion (Thermo Fisher Scientific, MA, USA). The gel then was stained with ethidium bromide and viewed under UV light. Fingerprints were analyzed using BioNumerics software, version 7.6.1 (Applied Maths, St-Martens-Latem, Belgium). Bands not detected automatically were manually assigned. Fingerprints were clustered according to the band-based coefficient, which measures similarity based upon common and different bands with 0.5% optimization and 0.5% tolerance of band matching.
Conjugation.
Conjugation experiments were performed as described previously (48) using isolate ACM-17 of the pMAL-1-linked clone and carrying blaOXA-72 as a donor and Escherichia coli J53, resistant to sodium azide, as a recipient. ACM-17 and E. coli J53 were mixed at a ratio of 4:1 (donor to recipient) in Luria-Bertani broth, and the mixture was incubated at 37°C for 1 h. To select for transconjugants, serial dilutions of the cultures were plated on UriSelect agar containing imipenem (4 μg/ml) and sodium azide (100 μg/ml).
Whole-genome sequencing.
DNA extraction was performed using the NucleoSpin tissue kit (Macherey-Nagel, Germany) according to the manufacturer’s instructions. Library preparation was done using the Nextera XT DNA library preparation kit (Illumina). Sequencing of the library was done on an Illumina MiSeq using a paired-end 500-cycle protocol with a read length of 250 bp. FastQC, version 1.0.0 (49), was used for quality control. Reads were trimmed by the Trimmomatic tool, v0.36 (50). Paired-end reads were assembled using SPAdes, v3.12.0 (51), and annotated using the RAST server (http://rast.nmpdr.org) (52).
Two isolates (ACM-2 and ACM-17) were additionally sequenced using PacBio long-read sequencing technology on the Sequel platform (Pacific Biosciences, CA, USA). ACM-2 represented the Tn2006-mediated clone, and ACM-17 represented the pMAL-1-mediated clone. Library preparation was done according to the manufacturer’s instructions for microbial multiplexing. G-tubes (Covaris, USA) were used for DNA shearing, and no size selection was performed. Resulting chromosomal contigs of ACM-2 and ACM-17 were corrected by Illumina data with Pilon, v1.23 (53), and the overlapping ends of chromosomes were trimmed after manual inspection of reads mapped by BWA-MEM algorithm as implemented in BWA, v0.7.17 (54), and Bowtie, v2.3.4.2 (55). Genome assembly was done using HGAP4 (56) with minimum seed coverage of 30. PCR-based amplification was used to fill the sequence gaps.
Genome analysis.
Resfinder (57), MLST 1.8 server, ISfinder database (58), BLAST (59), and the open reading frame (ORF) finder tool (59) were utilized to identify resistance genes, sequence types (STs), ISs, and plasmid identification and annotation, respectively. Mauve (version 2.3.1) was used for comparative genome alignments (60). The core genome alignments of each clone were used for outbreak analysis. Ape was used to infer basic phylogeny of the aligned core genomes (61). Adegenet was used to cluster genetic fragments that were found to be identical between the isolates from each outbreak and to perform a multivariate analysis of the genetic markers using the SeqTrack algorithm (62); this was used to visualize the genetic relatedness of the isolates spatially. plasmidSPAdes, version 3.10.1 (63), was employed to generate separate plasmid contigs, and the output was visualized through Bandage and an assembly graph viewer (64).
We used Outbreaker (28) to help elucidate the circulating clones that were directly linked to the studied outbreak. Outbreaker is based on collection dates and a reconstruction of the outbreak based on the evolution of core genome SNPs outside identified recombination spots in all studied genomes.
To detect recombinant regions, core genomes were aligned using Gubbins (65). Recombinations were masked using maskrc (https://github.com/kwongj/maskrc-svg).
Phylogenetic analysis.
For the purposes of phylogenetic analysis of all the recovered isolates, along with ACM-14, which was used as an outgroup, core genome sequences were extracted from the contigs using an in-house script. The script was used to extract all nonrepetitive homologous sequences that are longer than 399 bp using NUCmer, version 3.1 (66), output as generated by QUAST, version 5.0.0 (67). Core genome sequences were aligned by MAFFT, version 7.407 (68), using default gap penalties and the memsave parameter, FFT-NS-2 strategy, and iterative refinement with a maximum of two iterations. SNP sites then were extracted from aligned sequences using the SNP-sites tool, version 2.4.0 (69).
In order to infer the phylogeny of the two clones, quality-trimmed Illumina reads were mapped to the chromosomal sequences (ACM-2 or ACM-17) using Bowtie, version 2.3.4.2 (55). SNPs were consequently called using VarScan, version 2.4.3 (70), with minimum read depth set to 8, minimum base quality of 20, and variant allele frequency of ≥0.8. All sites where at least one isolate had a read depth of <8 were removed from the final data sets.
All three data sets were analyzed by jModelTest, version 2.1.10, to determine the most appropriate models of nucleotide substitution (71). Phylogenetic analyses were performed by RAxML, version 8.2.10 (72), and robustness of the inferred topologies was assessed by 500-bootstrap replicate analyses. Topologies of the trees were visualized using iTOL, version 4.3.2 (73), and edited by Inkscape, version 0.92 (www.inkscape.org), and Gimp, version 2.10.6 (www.gimp.org).
Plasmid analysis.
Sequence gaps resulting from short Illumina reads were closed using PCR and Sanger sequencing. Seven primer pairs were designed using SeqBuilder software (Lasergene, Madison, WI). For sequence analysis and annotation, the BLAST algorithm (www.ncbi.nlm.nih.gov/BLAST), the ISfinder database (www-is.biotoul.fr/), and the ORF finder tool (www.bioinformatics.org/sms/) were utilized. Comparative genome alignments were performed using Mauve, v2.3.1 (60).
Plasmid typing.
The PCR-based replicon typing method for A. baumannii developed by Bertini et al. (22) was used to determine the plasmid content of the 41 isolates. With this method, the 27 known A. baumannii replicase (rep) genes are grouped into 19 homology groups according to their nucleotide sequence similarities. Six multiplex PCRs were done using primers designed by Bertini et al. (22).
Accession number(s).
The draft genomes were deposited in the NCBI databases under the accession numbers listed in Table S3 in the supplemental material.
ACKNOWLEDGMENTS
This work was partially financed by the School of Arts and Sciences Research and Development Council at the Lebanese American University and by the National Sustainability Program I (NPU I; grant number LO1503), provided by the Ministry of Education Youth and Sports of the Czech Republic, the Charles University Research Fund–PROGRES (grant number Q39), and project no. CZ.02.1.01/0.0/0.0/16_019/0000787, Fighting Infectious Diseases. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
REFERENCES
- 1.Antunes LC, Visca P, Towner KJ. 2014. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71:292–301. doi: 10.1111/2049-632X.12125. [DOI] [PubMed] [Google Scholar]
- 2.Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46:1254–1263. doi: 10.1086/529198. [DOI] [PubMed] [Google Scholar]
- 3.Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A. 2007. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13:97–103. doi: 10.3201/eid1301.060716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kanamori H, Parobek CM, Weber DJ, van Duin D, Rutala WA, Cairns BA, Juliano JJ. 2015. Next-generation sequencing and comparative analysis of sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii at a large academic burn center. Antimicrob Agents Chemother 60:1249–1257. doi: 10.1128/AAC.02014-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190:8053–8064. doi: 10.1128/JB.00834-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939–951. doi: 10.1038/nrmicro1789. [DOI] [PubMed] [Google Scholar]
- 7.Fournier PE, Richet H. 2006. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 42:692–699. doi: 10.1086/500202. [DOI] [PubMed] [Google Scholar]
- 8.Higgins PG, Dammhayn C, Hackel M, Seifert H. 2010. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65:233–238. doi: 10.1093/jac/dkp428. [DOI] [PubMed] [Google Scholar]
- 9.Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. 2017. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 7:55. doi: 10.3389/fcimb.2017.00055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Poirel L, Nordmann P. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 12:826–836. doi: 10.1111/j.1469-0691.2006.01456.x. [DOI] [PubMed] [Google Scholar]
- 11.Brown S, Young HK, Amyes SG. 2005. Characterization of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 11:15–23. doi: 10.1111/j.1469-0691.2004.01016.x. [DOI] [PubMed] [Google Scholar]
- 12.Howard A, O'Donoghue M, Feeney A, Sleator RD. 2012. Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence 3:243–250. doi: 10.4161/viru.19700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Evans BA, Amyes SG. 2014. OXA β-lactamases. Clin Microbiol Rev 27:241–263. doi: 10.1128/CMR.00117-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471–3484. doi: 10.1128/AAC.01464-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mugnier PD, Poirel L, Naas T, Nordmann P. 2010. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 16:35–40. doi: 10.3201/eid1601.090852. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Chen Y, Yang Y, Liu L, Qiu G, Han X, Tian S, Zhao J, Chen F, Grundmann H, Li H, Sun J, Han L. 2018. High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study. BMC Infect Dis 18:491. doi: 10.1186/s12879-018-3359-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Al Atrouni A, Hamze M, Jisr T, Lemarié C, Eveillard M, Joly-Guillou ML, Kempf M. 2016. Wide spread of OXA-23-producing carbapenem resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int J Infect Dis 52:29–36. doi: 10.1016/j.ijid.2016.09.017. [DOI] [PubMed] [Google Scholar]
- 18.Moghnieh R, Araj GF, Awad L, Daoud Z, Mokhbat JE, Jisr T, Abdallah D, Azar N, Irani-Hakimeh N, Balkis MM, Youssef M, Karayakoupoglou G, Hamze M, Matar M, Atoui R, Abboud E, Feghali R, Yared N, Husni R. 2019. A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015–2016. Antimicrob Resist Infect Control 8:41. doi: 10.1186/s13756-019-0487-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, Saade D, Mokhbat J, Abboud E, Hamze M, Abboud E, Jisr T, Haddad A, Feghali R, Azar N, El-Zaatari M, Chedid M, Haddad C, Zouain Dib Nehme M, Barakat A, Husni R, Lebanese Society of Infectious Diseases Study Group (LSID Study Group). 2016. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis 46:64–70. doi: 10.1016/j.ijid.2016.03.010. [DOI] [PubMed] [Google Scholar]
- 20.Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. [DOI] [PubMed] [Google Scholar]
- 21.Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54:4168–4177. doi: 10.1128/AAC.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yoon EJ, Kim JO, Yang JW, Kim HS, Lee KJ, Jeong SH, Lee H, Lee K. 2017. The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother 72:2708–2714. doi: 10.1093/jac/dkx205. [DOI] [PubMed] [Google Scholar]
- 24.Kim DH, Choi JY, Kim HW, Kim SH, Chung DR, Peck KR, Thamlikitkul V, So TMK, Yasin R, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Song JH, Ko KS. 2013. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother 57:5239–5246. doi: 10.1128/AAC.00633-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hamidian M, Holt KE, Pickard D, Dougan G, Hall RM. 2014. A GC1 Acinetobacter baumannii isolate carrying AbaR3 and the aminoglycoside resistance transposon TnaphA6 in a conjugative plasmid. J Antimicrob Chemother 69:955–958. doi: 10.1093/jac/dkt454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Dortet L, Bonnin RA, Bernabeu S, Escaut L, Vittecoq D, Girlich D, Imanci D, Fortineau N, Naas T. 2016. First occurrence of OXA-72-producing Acinetobacter baumannii in Serbia. Antimicrob Agents Chemother 60:5724–5730. doi: 10.1128/AAC.01016-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Armalytė J, Jurėnas D, Krasauskas R, Čepauskas A, Sužiedėlienė E. 2018. The higBA toxin-antitoxin module from the opportunistic pathogen Acinetobacter baumannii–regulation, activity, and evolution. Front Microbiol 9:732. doi: 10.3389/fmicb.2018.00732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jombart T, Cori A, Didelot X, Cauchemez S, Fraser C, Ferguson N. 2014. Bayesian reconstruction of disease outbreaks by combining epidemiologic and genomic data. PLoS Comput Biol 10:e1003457. doi: 10.1371/journal.pcbi.1003457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Nigro S, Hall RM. 2015. Distribution of the blaOXA-23-containing transposons Tn2006 and Tn2008 in Australian carbapenem-resistant Acinetobacter baumannii isolates. J Antimicrob Chemother 70:2409–2411. doi: 10.1093/jac/dkv102. [DOI] [PubMed] [Google Scholar]
- 30.Hammoudi D, Moubareck CA, Hakime N, Houmani M, Barakat A, Najjar Z, Suleiman M, Fayad N, Sarraf R, Sarkis DK. 2015. Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemase in Lebanon. Int J Infect Dis 36:56–61. doi: 10.1016/j.ijid.2015.05.015. [DOI] [PubMed] [Google Scholar]
- 31.Mugnier P, Poirel L, Pitout M, Nordmann P. 2008. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin Microbiol Infect 14:879–882. doi: 10.1111/j.1469-0691.2008.02056.x. [DOI] [PubMed] [Google Scholar]
- 32.Hamidian M, Hawkey J, Wick R, Holt KE, Hall RM. 2019. Evolution of a clade of Acinetobacter baumannii global clone 1, lineage 1 via acquisition of carbapenem- and aminoglycoside-resistance genes and dispersion of ISAba1. Microb Genom 5:e000242. doi: 10.1099/mgen.0.000242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Chagas TP, Silveira MC, Albano RM, Carvalho-Assef AP, Asensi MD. 2015. Draft genome sequence of a multidrug-resistant Acinetobacter baumannii ST15 (CC15) isolated from Brazil. Mem Inst Oswaldo Cruz 110:691–692. doi: 10.1590/0074-02760150158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pfeifer Y, Trifonova A, Pietsch M, Brunner M, Todorova I, Gergova I, Wilharm G, Werner G, Savov E. 2017. Clonal transmission of gram-negative bacteria with carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian hospital. Microb Drug Resist 23:301–307. doi: 10.1089/mdr.2016.0059. [DOI] [PubMed] [Google Scholar]
- 35.Lowe M, Ehlers MM, Ismail F, Peirano G, Becker PJ, Pitout JDD, Kock MM. 2018. Acinetobacter baumannii: epidemiological and beta-lactamase data from two tertiary academic hospitals in Tshwane, South Africa. Front Microbiol 9:1280. doi: 10.3389/fmicb.2018.01280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. 2014. Dissemination of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan. Antimicrob Agents Chemother 58:2916–2920. doi: 10.1128/AAC.01212-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Heaton BE, Herrou J, Blackwell AE, Wysocki VH, Crosson S. 2012. Molecular structure and function of the novel BrnT/BrnA toxin-antitoxin system of Brucella abortus. J Biol Chem 287:12098–12110. doi: 10.1074/jbc.M111.332163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Noinaj N, Guillier M, Barnard TJ, Buchanan SK. 2010. TonB-dependent transporters: regulation, structure, and function. Annu Rev Microbiol 64:43–60. doi: 10.1146/annurev.micro.112408.134247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rosado CJ, Kondos S, Bull TE, Kuiper MJ, Law RH, Buckle AM, Voskoboinik I, Bird PI, Trapani JA, Whisstock JC, Dunstone MA. 2008. The MACPF/CDC family of pore-forming toxins. Cell Microbiol 10:1765–1774. doi: 10.1111/j.1462-5822.2008.01191.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Datta S, Mitra S, Chattopadhyay P, Som T, Mukherjee S, Basu S. 2017. Spread and exchange of bla NDM-1 in hospitalized neonates: role of mobilizable genetic elements. Eur J Clin Microbiol Infect Dis 36:255–265. doi: 10.1007/s10096-016-2794-6. [DOI] [PubMed] [Google Scholar]
- 41.Lopes BS, Amyes SG. 2012. Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. J Med Microbiol 61:1103–1108. doi: 10.1099/jmm.0.044156-0. [DOI] [PubMed] [Google Scholar]
- 42.Andersen SB, Ghoul M, Griffin AS, Petersen B, Johansen HK, Molin S. 2017. Diversity, prevalence, and longitudinal occurrence of type II toxin-antitoxin systems of Pseudomonas aeruginosa infecting cystic fibrosis lungs. Front Microbiol 8:1180. doi: 10.3389/fmicb.2017.01180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.De Gregorio E, Del Franco M, Martinucci M, Roscetto E, Zarrilli R, Di Nocera PP. 2015. Biofilm-associated proteins: news from Acinetobacter. BMC Genomics 16:933. doi: 10.1186/s12864-015-2136-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Smith RL, O'Toole JF, Maguire ME, Sanders CR II. 1994. Membrane topology of Escherichia coli diacylglycerol kinase. J Bacteriol 176:5459–5465. doi: 10.1128/jb.176.17.5459-5465.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Park YK, Ko KS. 2015. Effect of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on killing Acinetobacter baumannii by colistin. J Microbiol 53:53–59. doi: 10.1007/s12275-015-4498-5. [DOI] [PubMed] [Google Scholar]
- 46.Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing, 29th ed, M100 Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
- 47.Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, Heersma H, Dijkshoorn L. 2005. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 43:4328–4335. doi: 10.1128/JCM.43.9.4328-4335.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Walsh F, Cooke NM, Smith SG, Moran GP, Cooke FJ, Ivens A, Wain J, Rogers TR. 2010. Comparison of two DNA microarrays for detection of plasmid-mediated antimicrobial resistance and virulence factor genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae. Int J Antimicrob Agents 35:593–598. doi: 10.1016/j.ijantimicag.2010.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Andrews S. 2010. FastQC: a quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk.
- 50.Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Aziz RK, Devoid S, Disz T, Edwards RA, Henry CS, Olsen GJ, Olson R, Overbeek R, Parrello B, Pusch GD, Stevens RL, Vonstein V, Xia F. 2012. SEED servers: high performance access to the SEED genomes, annotations, and metabolic models. PLoS One 7:e48053. doi: 10.1371/journal.pone.0048053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Walker BJ, Abeel T, Shea T, Priest M, Abouelliel A, Sakthikumar S, Cuomo CA, Zeng Q, Wortman J, Young SK, Earl AM. 2014. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 9:e112963. doi: 10.1371/journal.pone.0112963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Li H. 2013. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv 1303.3997 [q-bio.GN] https://arXiv.org/abs/1303.3997.
- 55.Langmead B, Salzberg S. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Chin C-S, Alexander DH, Marks P, Klammer AA, Drake J, Heiner C, Clum A, Copeland A, Huddleston J, Eichler EE, Turner SW, Korlach J. 2013. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods 10:563–569. doi: 10.1038/nmeth.2474. [DOI] [PubMed] [Google Scholar]
- 57.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32–D36. doi: 10.1093/nar/gkj014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius JU, Schuler GD, Schriml LM, Sequeira E, Tatusova TA, Wagner L. 2003. Database resources of the National Center for Biotechnology. Nucleic Acids Res 31:28–33. doi: 10.1093/nar/gkg033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Darling AC, Mau B, Blattner FR, Perna NT. 2004. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 14:1394–1403. doi: 10.1101/gr.2289704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Paradis E, Claude J, Strimmer K. 2004. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289–290. doi: 10.1093/bioinformatics/btg412. [DOI] [PubMed] [Google Scholar]
- 62.Jombart T. 2008. adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics 24:1403–1405. doi: 10.1093/bioinformatics/btn129. [DOI] [PubMed] [Google Scholar]
- 63.Antipov D, Hartwick N, Shen M, Raiko M, Lapidus A, Pevzner PA. 2016. plasmidSPAdes: assembling plasmids from whole genome sequencing data. Bioinformatics 32:3380–3387. doi: 10.1093/bioinformatics/btw493. [DOI] [PubMed] [Google Scholar]
- 64.Wick RR, Schultz MB, Zobel J, Holt KE. 2015. Bandage: interactive visualization of de novo genome assemblies. Bioinformatics 31:3350–3352. doi: 10.1093/bioinformatics/btv383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Croucher NJ, Hanage WP, Harris SR, McGee L, van der Linden M, de Lencastre H, Sá-Leão R, Song JH, Ko KS, Beall B, Klugman KP, Parkhill J, Tomasz A, Kristinsson KG, Bentley SD. 2014. Variable recombination dynamics during the emergence, transmission and “disarming” of a multidrug-resistant pneumococcal clone. BMC Biol 12:49. doi: 10.1186/1741-7007-12-49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Delcher AL, Phillippy A, Carlton J, Salzberg SL. 2002. Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res 30:2478–2483. doi: 10.1093/nar/30.11.2478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075. doi: 10.1093/bioinformatics/btt086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Katoh K, Standley DM. 2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30:772–780. doi: 10.1093/molbev/mst010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Page AJ, Taylor B, Delaney AJ, Soares J, Seemann T, Keane JA, Harris SR. 2016. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments. Microb Genom 2:e000056. doi: 10.1099/mgen.0.000056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. 2012. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22:568–576. doi: 10.1101/gr.129684.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Darriba D, Taboada GL, Doallo R, Posada D. 2012. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods 9:772. doi: 10.1038/nmeth.2109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30:1312–1313. doi: 10.1093/bioinformatics/btu033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Letunic I, Bork P. 2016. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 44:W242–W245. doi: 10.1093/nar/gkw290. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.